Used at a sub-toxic dosage, chronic fenretinide administration was able to delay locomotor deficit progression in ALS mice, preserving muscle cells and motor neurons from mutant SOD1 toxicity [29]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.